Hiromachi, Japan

Kimio Iino


Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 90(Granted Patents)


Location History:

  • Hinomachi, JP (1996)
  • Tokyo, JP (1985 - 1997)
  • Hiromachi, JP (1986 - 1997)

Company Filing History:


Years Active: 1985-1997

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Inventor Kimio Iino

Introduction

Kimio Iino, an accomplished inventor based in Hiromachi, Japan, has made significant contributions to the field of pharmaceuticals with a focus on anti-tumor compounds. With an impressive portfolio of 9 patents, Iino's work is characterized by his dedication to advancing medical therapies.

Latest Patents

Among Iino's most recent patents are innovations related to radicicol derivatives. These derivatives, particularly those with acylated hydroxy groups, exhibit valuable anti-tumor activity and can serve as important chemical intermediates. Another noteworthy patent involves anti-tumor platinum complexes. These compounds demonstrate therapeutic potential and are synthesized by reacting an amine-platinum complex with specific organic groups.

Career Highlights

Iino is currently affiliated with Sankyo Company, Limited, a prominent player in the pharmaceutical industry. His work has been pivotal in developing compounds that address critical health challenges, particularly in the field of oncology.

Collaborations

Throughout his career, Kimio Iino has collaborated with esteemed colleagues, including Yukio Sugimura and Toshihiko Hashimoto. These partnerships have further bolstered his research efforts and contributed to the successful development of his innovative projects.

Conclusion

In conclusion, Kimio Iino's contributions to pharmaceutical innovations, particularly in anti-tumor therapies, reflect his commitment to improving health outcomes through scientific advancements. His patents not only showcase his creativity and technical expertise but also highlight the importance of collaboration in the pursuit of groundbreaking inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…